The antiviral drug telbivudine prevents perinatal transmission of hepatitis B virus (HBV), a new study says.
Hepatitis B virus, which has infected nearly two billion people worldwide, is a leading cause of liver disease.
"If we are to decrease the global burden of hepatitis B, we need to
start by addressing mother-to-infant transmission, which is the primary
pathway of HBV infection," said study author Yuming Wang from Institute
for Infectious Diseases, Southwest Hospital, Chongqing, China.
Read more...Labels: perinatal transmission, telbivudine